论文部分内容阅读
目的观察α-细辛脑联合酚妥拉明及阿拉明佐治小儿支气管肺炎的疗效。方法将2006年10月至2008年10月住院的90例支气管肺炎患儿按住院单双号分为观察组40例和对照组50例。对照组给予常规治疗,治疗组在常规治疗的基础上加用α-细辛脑联合酚妥拉明及阿拉明静脉滴注,比较两组治疗前后症状的缓解、肺部湿啰音变化和治愈率的情况。结果治疗组加用α-细辛脑联合酚妥拉明及阿拉明静脉滴注与对照组疗效比较,差异有统计学意义(P<0.01)。结论α-细辛脑联合酚妥拉明及阿拉明静脉滴注治疗小儿支气管肺炎的疗效显著,值得在临床上推广应用。
Objective To observe the effect of α-asarone combined with phentolamine and Alamin on pediatric bronchopneumonia. Methods 90 cases of bronchial pneumonia hospitalized from October 2006 to October 2008 were divided into observation group (40 cases) and control group (50 cases) according to the hospital admission number. The patients in the control group were treated with conventional therapy. The patients in the treatment group were treated with intravenous α-asarone combined with phentolamine and alendrine. The relief of symptoms, the change of the lung wet rales and the cure were compared Rate of the situation. Results The treatment group plus a-asarone combined phentolamine and alendrine intravenous infusion compared with the control group, the difference was statistically significant (P <0.01). Conclusion Aspirin combined with intravenous infusion of phentolamine and alendronate in children with bronchial pneumonia has significant curative effect and is worth popularizing in clinic.